Posts Tagged ‘therapeutics’
Taligen Closes $10M Series B Financing Tranche
24 Aug 2010Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company’s product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Search. The Pharma Letter · Home · 30 Day Premium Trial · Pharmaceuticals · Biotechnology · Generics · Events · Companies · Drugs · Subscribe. Keywords: Cell Therapeutics, Pixantrone, Pixuvri, EMEA, FDA, Europe, USA, Pediatric …
- No Comments
- Tags: directive, emea, europe-, fda, generics, nanobiotechnology-, pixuvri, premium-trial, therapeutics
Cell Therapeutics pays off all its 2010 debt
1 Jul 2010Biotechnology company Cell Therapeutics Inc.
Cell Therapeutics agrees to sell preferred stock
24 May 2010Biotechnology company Cell Therapeutics Inc. said Monday it has agreed to sell stock and warrants to a group of three institutional investors for up to $34.1 million.
Astellas Pharma Inc, a global pharmaceutical company, and OSI Pharmaceuticals, Inc, a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes and obesity, have entered into a definitive merger agreement under which Astellas will acquire OSI.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells (“CSCs …
Logical Therapeutics Initiates Enrollment In New Gastrointestinal Safety Study In Osteoarthritis Patients
27 Apr 2010Logical Therapeutics, Inc., a Waltham, Mass.-based biotechnology company announced today the initiation of a Phase 2b clinical study to evaluate the gastrointestinal (GI) safety of its investigational drug LT-NS001 (naproxen etemesil).
RXi Pharma Signs Development Deal
12 Apr 2010Biotechnology company said Monday it is collaborating with miRagen Therapeutics Inc. to develop potential treatments for heart and muscle diseases.
RXi Pharma signs development deal with miRagen
12 Apr 2010Biotechnology company RXi Pharmaceuticals Corp. said Monday it is collaborating with miRagen Therapeutics Inc. to develop potential treatments for heart and muscle diseases.
Fate Therapeutics, Inc. announced today a definitive agreement to acquire Verio Therapeutics Inc., a privately held biotechnology company based in Ottawa, Ontario, which is developing drug candidates targeting the activation of endogenous stem cells
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (4750)
Archives
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- December 2008
- November 2008
- October 2008
- August 2008
- July 2008
- June 2008
- April 2008
- February 2008
- January 2008
- December 2007
- August 2007
- July 2007
- June 2007
- April 2007
- February 2007
- December 2006
- September 2006
- August 2006
- New type of anti-malarial compound discovered
- Mechanisms and function of a type of mysterious immune cell discovered
- Molecules involved in ‘touch’ identified: Could lead to new treatments for pain, deafness and cardiac function
- Why fish oils work swimmingly against inflammation and diabetes
- Scientists unwrap DNA packaging to gain insight into cells
- Nanobiotechnology advances point to medical applications
- Generex Biotechnology Initiates Social Media Campaign for Its Corporate and e-Commerce Websites
- Lima beans domesticated twice
- Commercial organic farms have better fruit and soil, lower environmental impact, study finds
- Live imaging puts new light on stem cell division
